Close
Solutions
Online Inquiry
Global Services

scFv Generation from Phage Display Library

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

In addition to scFv generation from Hybridoma cells, Creative Biolabs also provides custom one-stop CAR development solution for generating scFv from Phage display library. This scFv phage display service mainly includes library construction and screening.

scFv generation from Phage display library

Adapted from The Scripps Research Institute website.

With our excellent scientists, Creative Biolabs can establish an immunized phage display scFv library, from which a scFv against the interested antigen can be screened out. Firstly, we will design the suitable primers for cloning the antibody genes from B lymphocytes of several different species, followed by integrating the antibody genes into a phage display vector. The recombinant phagemid population will then be transformed into Escherichia coli in which they can produce phage-displayd scFv depending on the helper phage. In the last critical step, we will screen this scFv phage display library with the specific antigen from our customers or the recombinant antigen prepared ourselves. Creative Biolabs also provides molecular characterization during scFv generation such as western blot, ELISA or DNA sequencing. Creative Biolabs guarantees that our scFv phage library can achieve a capacity of over 1×1010 clones.

Depending on our various technology platforms, Creative Biolabs can offer you world-class scFv construction services, which can greatly accelerate your research progress with much lower unpredictable risk. Please do not hesitate to contact us.

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.